Advertisement
Review Article| Volume 26, ISSUE 1, P185-209, March 2006

Download started.

Ok

Chemically Induced Seizures

      Generalized seizure activity may be a presenting symptom of poisoning or a preterminal manifestation of serious toxicity. Seizures may result from a large number of drugs and toxins, such as isoniazid (INH), carbon monoxide, theophylline, cyclic antidepressants, and salicylates. Additionally, withdrawal states, such as from ethanol and sedative hypnotic agents, may induce refractory seizure activity.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. American Association of Poison Control Centers. Toxic Exposure Surveillance System. Available at: http://www.aapcc.org. Accessed November 2004.

        • DeLorenzo R.J.
        • Hauser W.A.
        • Towne A.R.
        • et al.
        A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia.
        Neurology. 1996; 46: 1029-1035
        • Olson K.R.
        • Kearney T.E.
        • Dyer J.E.
        • et al.
        Seizures associated with poisoning and drug overdose.
        Am J Emerg Med. 1994; 12: 392-395
        • Thundiyil J.G.K.T.
        • Olson K.R.
        Evolving epidemiology of drug-induced seizures reported to a poison control center system.
        J Toxicol Clin Toxicol. 2004; 42: 730
        • Lowenstein D.H.
        • Bleck T.
        • Macdonald R.L.
        It's time to revise the definition of status epilepticus.
        Epilepsia. 1999; 40: 120-122
        • Marik P.E.
        • Varon J.
        The management of status epilepticus.
        Chest. 2004; 126: 582-591
        • Loscher W.
        Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.
        Prog Neurobiol. 1998; 54: 721-741
        • Fountain N.B.
        • Lothman E.W.
        Pathophysiology of status epilepticus.
        J Clin Neurophysiol. 1995; 12: 326-342
        • Cohen P.G.
        The metabolic basis for the genesis of seizures: the role of the potassium-ammonia axis.
        Med Hypotheses. 1984; 13: 311-316
        • Dyer J.E.
        • Roth B.
        • Hyma B.A.
        Gamma-hydroxybutyrate withdrawal syndrome.
        Ann Emerg Med. 2001; 37: 147-153
        • Morimoto K.
        • Fahnestock M.
        • Racine R.J.
        Kindling and status epilepticus models of epilepsy: rewiring the brain.
        Prog Neurobiol. 2004; 73: 1-60
        • Teitelbaum J.S.
        • Zatorre R.J.
        • Carpenter S.
        • et al.
        Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels.
        N Engl J Med. 1990; 322: 1781-1787
        • Shadnia S.
        • Moiensadat M.
        • Abdollahi M.
        A case of acute strychnine poisoning.
        Vet Hum Toxicol. 2004; 46: 76-79
        • Walker I.A.
        • Slovis C.M.
        Lidocaine in the treatment of status epilepticus.
        Acad Emerg Med. 1997; 4: 918-922
        • Marley R.J.
        • Witkin J.M.
        • Goldberg S.R.
        A pharmacogenetic evaluation of the role of local anesthetic actions in the cocaine kindling process.
        Brain Res. 1991; 562: 251-257
        • Derlet R.W.
        • Albertson T.E.
        • Tharratt R.S.
        Lidocaine potentiation of cocaine toxicity.
        Ann Emerg Med. 1991; 20: 135-138
        • Linnoila M.
        • Mefford I.
        • Nutt D.
        • et al.
        NIH conference. Alcohol withdrawal and noradrenergic function.
        Ann Intern Med. 1987; 107: 875-889
        • Tuovinen K.
        Organophosphate-induced convulsions and prevention of neuropathological damages.
        Toxicology. 2004; 196: 31-39
        • Fredholm B.B.
        • IJzerman A.P.
        • Jacobson K.A.
        • et al.
        International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
        Pharmacol Rev. 2001; 53: 527-552
        • Etherington L.A.
        • Frenguelli B.G.
        Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype–dependent manner.
        Eur J Neurosci. 2004; 19: 2539-2550
        • Yokoyama H.
        • Sato M.
        • Iinuma K.
        • et al.
        Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats.
        Neurosci Lett. 1996; 217: 194-196
        • Kamei C.
        • Ohuchi M.
        • Sugimoto Y.
        • et al.
        Mechanism responsible for epileptogenic activity by first-generation H1-antagonists in rats.
        Brain Res. 2000; 887: 183-186
        • Delanty N.
        • Vaughan C.J.
        • French J.A.
        Medical causes of seizures.
        Lancet. 1998; 352: 383-390
        • Carbone J.R.
        The neuroleptic malignant and serotonin syndromes.
        Emerg Med Clin North Am. 2000; 18 (x): 317-325
        • Knight B.
        • Thomson N.
        • Perry G.
        Seizures due to norpethidine toxicity.
        Aust N Z J Med. 2000; 30: 513
        • Armstrong P.J.
        • Bersten A.
        Normeperidine toxicity.
        Anesth Analg. 1986; 65: 536-538
        • Spiller H.A.
        • Gorman S.E.
        • Villalobos D.
        • et al.
        Prospective multicenter evaluation of tramadol exposure.
        J Toxicol Clin Toxicol. 1997; 35: 361-364
        • Sloth Madsen P.
        • Strom J.
        • Reiz S.
        • et al.
        Acute propoxyphene self-poisoning in 222 consecutive patients.
        Acta Anaesthesiol Scand. 1984; 28: 661-665
        • Alldredge B.K.
        • Lowenstein D.H.
        • Simon R.P.
        Seizures associated with recreational drug abuse.
        Neurology. 1989; 39: 1037-1039
        • Spivey W.H.
        • Euerle B.
        Neurologic complications of cocaine abuse.
        Ann Emerg Med. 1990; 19: 1422-1428
        • Graeme K.A.
        New drugs of abuse.
        Emerg Med Clin North Am. 2000; 18: 625-636
        • Freese T.E.
        • Miotto K.
        • Reback C.J.
        The effects and consequences of selected club drugs.
        J Subst Abuse Treat. 2002; 23: 151-156
        • Koppel B.S.
        • Samkoff L.
        • Daras M.
        Relation of cocaine use to seizures and epilepsy.
        Epilepsia. 1996; 37: 875-878
        • O'Dell L.E.
        • Kreifeldt M.J.
        • George F.R.
        • et al.
        The role of serotonin(2) receptors in mediating cocaine-induced convulsions.
        Pharmacol Biochem Behav. 2000; 65: 677-681
        • Yao I.C.M.S.
        • O'Koren K.
        • Guffey M.A.
        • et al.
        Delayed onset of seizure in a body stuffer.
        J Toxicol Clin Toxicol. 2003; 41: 650
        • Mason P.E.
        • Kerns II, W.P.
        Gamma hydroxybutyric acid (GHB) intoxication.
        Acad Emerg Med. 2002; 9: 730-739
        • Hu R.Q.
        • Cortez M.A.
        • Man H.Y.
        • et al.
        Gamma-hydroxybutyric acid–induced absence seizures in GluR2 null mutant mice.
        Brain Res. 2001; 897: 27-35
        • Hu R.Q.
        • Cortez M.A.
        • Man H.Y.
        • et al.
        Alteration of GLUR2 expression in the rat brain following absence seizures induced by gamma-hydroxybutyric acid.
        Epilepsy Res. 2001; 44: 41-51
        • Craig K.
        • Gomez H.F.
        • McManus J.L.
        • et al.
        Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
        J Emerg Med. 2000; 18: 65-70
        • Mycyk M.B.
        • Wilemon C.
        • Aks S.E.
        Two cases of withdrawal from 1,4-Butanediol use.
        Ann Emerg Med. 2001; 38: 345-346
        • McDonough M.
        • Kennedy N.
        • Glasper A.
        • et al.
        Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
        Drug Alcohol Depend. 2004; 75: 3-9
        • Bania T.C.
        • Ashar T.
        • Press G.
        • et al.
        Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model.
        Acad Emerg Med. 2003; 10: 697-704
        • Barton C.H.
        • Sterling M.L.
        • Vaziri N.D.
        Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay.
        Ann Emerg Med. 1981; 10: 243-246
        • McCarron M.M.
        • Schulze B.W.
        • Thompson G.A.
        • et al.
        Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases.
        Ann Emerg Med. 1981; 10: 237-242
        • Vieira L.
        • Weiner A.
        Ketamine abusers presenting to the emergency department: a case series.
        J Toxicol Clin Toxicol. 1998; 36: 505
        • Borris D.J.
        • Bertram E.H.
        • Kapur J.
        Ketamine controls prolonged status epilepticus.
        Epilepsy Res. 2000; 42: 117-122
        • Mewasingh L.D.
        • Sekhara T.
        • Aeby A.
        • et al.
        Oral ketamine in paediatric non-convulsive status epilepticus.
        Seizure. 2003; 12: 483-489
        • Isbell H.F.H.
        • Wikler A.
        • Belleville R.E.
        • et al.
        An experimental study of the etiology of “rum fits” and delirium tremens.
        Q J Stud Alcohol. 1955; 16: 1-33
        • Victor M.
        • Adams R.D.
        The effect of alcohol on the nervous system.
        Res Publ Assoc Res Nerv Ment Dis. 1953; 32: 526-573
        • Nolop K.B.
        • Natow A.
        Unprecedented sedative requirements during delirium tremens.
        Crit Care Med. 1985; 13: 246-247
        • Lineaweaver W.C.
        • Anderson K.
        • Hing D.N.
        Massive doses of midazolam infusion for delirium tremens without respiratory depression.
        Crit Care Med. 1988; 16: 294-295
        • Coomes T.R.
        • Smith S.W.
        Successful use of propofol in refractory delirium tremens.
        Ann Emerg Med. 1997; 30: 825-828
        • McCowan C.
        • Marik P.
        Refractory delirium tremens treated with propofol: a case series.
        Crit Care Med. 2000; 28: 1781-1784
        • Young G.P.
        • Rores C.
        • Murphy C.
        • et al.
        Intravenous phenobarbital for alcohol withdrawal and convulsions.
        Ann Emerg Med. 1987; 16: 847-850
        • Petursson H.
        The benzodiazepine withdrawal syndrome.
        Addiction. 1994; 89: 1455-1459
        • Spivey W.H.
        Flumazenil and seizures: analysis of 43 cases.
        Clin Ther. 1992; 14: 292-305
        • Seger D.L.
        Flumazenil—treatment or toxin.
        J Toxicol Clin Toxicol. 2004; 42: 209-216
        • Greenberg M.I.
        • Hendrickson R.G.
        Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement.
        J Toxicol Clin Toxicol. 2003; 41: 83-85
        • Green L.B.
        • Nelson V.S.
        Death after acute withdrawal of intrathecal baclofen: case report and literature review.
        Arch Phys Med Rehabil. 1999; 80: 1600-1604
        • Peng C.T.
        • Ger J.
        • Yang C.C.
        • et al.
        Prolonged severe withdrawal symptoms after acute-on-chronic baclofen overdose.
        J Toxicol Clin Toxicol. 1998; 36: 359-363
        • Kofler M.
        • Arturo Leis A.
        Prolonged seizure activity after baclofen withdrawal.
        Neurology. 1992; 42: 697-698
        • Khorasani A.
        • Peruzzi W.T.
        Dantrolene treatment for abrupt intrathecal baclofen withdrawal.
        Anesth Analg. 1995; 80: 1054-1056
        • Pimentel L.
        • Trommer L.
        Cyclic antidepressant overdoses. A review.
        Emerg Med Clin North Am. 1994; 12: 533-547
        • Frommer D.A.
        • Kulig K.W.
        • Marx J.A.
        • et al.
        Tricyclic antidepressant overdose. A review.
        JAMA. 1987; 257: 521-526
        • Hulten B.A.
        • Adams R.
        • Askenasi R.
        • et al.
        Predicting severity of tricyclic antidepressant overdose.
        J Toxicol Clin Toxicol. 1992; 30: 161-170
        • Emerman C.L.
        • Connors Jr., A.F.
        • Burma G.M.
        Level of consciousness as a predictor of complications following tricyclic overdose.
        Ann Emerg Med. 1987; 16: 326-330
        • Bailey B.
        • Buckley N.A.
        • Amre D.K.A.
        Meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose.
        J Toxicol Clin Toxicol. 2004; 42: 877-888
        • McCabe J.L.
        • Cobaugh D.J.
        • Menegazzi J.J.
        • et al.
        Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate, and hyperventilation.
        Ann Emerg Med. 1998; 32: 329-333
        • Callaham M.
        • Schumaker H.
        • Pentel P.
        Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning.
        J Pharmacol Exp Ther. 1988; 245: 216-220
        • Isbister G.K.
        • Bowe S.J.
        • Dawson A.
        • et al.
        Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.
        J Toxicol Clin Toxicol. 2004; 42: 277-285
        • Raju G.V.
        • Kumar T.C.
        • Khanna S.
        Seizures associated with sertraline.
        Can J Psychiatry. 2000; 45: 491
        • Kelly C.A.
        • Dhaun N.
        • Laing W.J.
        • et al.
        Comparative toxicity of citalopram and the newer antidepressants after overdose.
        J Toxicol Clin Toxicol. 2004; 42: 67-71
        • Fuller M.A.
        Drug information handbook for psychiatry.
        3rd edition. Lexi-Comp, Husdon (OH)2002
        • Belson M.G.
        • Kelley T.R.
        Bupropion exposures: clinical manifestations and medical outcome.
        J Emerg Med. 2002; 23: 223-230
        • Druteika D.
        • Zed P.J.
        Cardiotoxicity following bupropion overdose.
        Ann Pharmacother. 2002; 36: 1791-1795
        • Paris P.A.
        • Saucier J.R.
        ECG conduction delays associated with massive bupropion overdose.
        J Toxicol Clin Toxicol. 1998; 36: 595-598
        • Wills B.K.M.
        • Aks S.
        QRS prolongation associated with bupropion ingestion.
        J Toxicol Clin Toxicol. 2004; 42: 724
        • Blythe D.
        • Hackett L.P.
        Cardiovascular and neurological toxicity of venlafaxine.
        Hum Exp Toxicol. 1999; 18: 309-313
        • Cumpston K.C.M.
        • Pallasch E.
        Massive venlafaxine overdose resulting in arrhythmogenic death.
        J Toxicol Clin Toxicol. 2003; 41: 659
        • Whyte I.M.
        • Dawson A.H.
        • Buckley N.A.
        Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
        QJM. 2003; 96: 369-374
        • Hedges D.
        • Jeppson K.
        • Whitehead P.
        Antipsychotic medication and seizures: a review.
        Drugs Today (Barc). 2003; 39: 551-557
        • Lee K.C.
        • Finley P.R.
        • Alldredge B.K.
        Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings.
        Expert Opin Drug Saf. 2003; 2: 233-247
        • Lee J.W.
        • Crismon M.L.
        • Dorson P.G.
        Seizure associated with olanzapine.
        Ann Pharmacother. 1999; 33: 554-556
        • Woolley J.
        • Smith S.
        Lowered seizure threshold on olanzapine.
        Br J Psychiatry. 2001; 178: 85-86
        • Wyderski R.J.
        • Starrett W.G.
        • Abou-Saif A.
        Fatal status epilepticus associated with olanzapine therapy.
        Ann Pharmacother. 1999; 33: 787-789
        • Timmer R.T.
        • Sands J.M.
        Lithium intoxication.
        J Am Soc Nephrol. 1999; 10: 666-674
        • Amdisen A.
        Clinical features and management of lithium poisoning.
        Med Toxicol Adverse Drug Exp. 1988; 3: 18-32
        • Kores B.
        • Lader M.H.
        Irreversible lithium neurotoxicity: an overview.
        Clin Neuropharmacol. 1997; 20: 283-299
      2. Position paper. Whole bowel irrigation.
        J Toxicol Clin Toxicol. 2004; 42: 843-854
        • Linakis J.G.
        • Savitt D.L.
        • Wu T.Y.
        • et al.
        Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice.
        J Toxicol Clin Toxicol. 1998; 36: 309-313
        • Linakis J.G.
        • Eisenberg M.S.
        • Lacouture P.G.
        • et al.
        Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model.
        Pharmacol Toxicol. 1992; 70: 38-40
        • Roberge R.J.
        • Martin T.G.
        • Schneider S.M.
        Use of sodium polystyrene sulfonate in a lithium overdose.
        Ann Emerg Med. 1993; 22: 1911-1915
        • Gehrke J.C.
        • Watling S.M.
        • Gehrke C.W.
        • et al.
        In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
        Am J Emerg Med. 1996; 14: 37-38
        • Jaeger A.
        • Sauder P.
        • Kopferschmitt J.
        • et al.
        When should dialysis be performed in lithium poisoning? A kinetic study in 14 cases of lithium poisoning.
        J Toxicol Clin Toxicol. 1993; 31: 429-447
        • Lawson A.A.
        • Northridge D.B.
        Dextropropoxyphene overdose. Epidemiology, clinical presentation and management.
        Med Toxicol Adverse Drug Exp. 1987; 2: 430-444
        • Stork C.M.
        • Redd J.T.
        • Fine K.
        • et al.
        Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate—a case report.
        J Toxicol Clin Toxicol. 1995; 33: 179-183
        • Whitcomb D.C.
        • Gilliam III, F.R.
        • Starmer C.F.
        • et al.
        Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine.
        J Clin Invest. 1989; 84: 1629-1636
        • Potschka H.
        • Friderichs E.
        • Loscher W.
        Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy.
        Br J Pharmacol. 2000; 131: 203-212
        • Gardner J.S.
        • Blough D.
        • Drinkard C.R.
        • et al.
        Tramadol and seizures: a surveillance study in a managed care population.
        Pharmacotherapy. 2000; 20: 1423-1431
        • Tobias J.D.
        Seizure after overdose of tramadol.
        South Med J. 1997; 90: 826-827
        • Gasse C.
        • Derby L.
        • Vasilakis-Scaramozza C.
        • et al.
        Incidence of first-time idiopathic seizures in users of tramadol.
        Pharmacotherapy. 2000; 20: 629-634
        • From the Centers for Disease Control and Prevention
        Water hemlock poisoning—Maine, 1992.
        JAMA. 1994; 271: 1475
        • Heath K.B.
        A fatal case of apparent water hemlock poisoning.
        Vet Hum Toxicol. 2001; 43: 35-36
        • Michelot D.
        • Toth B.
        Poisoning by Gyromitra esculenta—a review.
        J Appl Toxicol. 1991; 11: 235-243
        • Karlson-Stiber C.
        • Persson H.
        Cytotoxic fungi—an overview.
        Toxicon. 2003; 42: 339-349
      3. US Food and Drug Administration. Consumer alert for ephedrine alkaloids. Available at: http://www.fda.gov. Accessed November 2004.

        • Haller C.A.
        • Benowitz N.L.
        Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
        N Engl J Med. 2000; 343: 1833-1838
        • Tyagi A.
        • Delanty N.
        Herbal remedies, dietary supplements, and seizures.
        Epilepsia. 2003; 44: 228-235
        • Perucca E.
        • Gram L.
        • Avanzini G.
        • et al.
        Antiepileptic drugs as a cause of worsening seizures.
        Epilepsia. 1998; 39: 5-17
        • Spiller H.A.
        • Carlisle R.D.
        Status epilepticus after massive carbamazepine overdose.
        J Toxicol Clin Toxicol. 2002; 40: 81-90
        • Sztajnkrycer M.D.
        Valproic acid toxicity: overview and management.
        J Toxicol Clin Toxicol. 2002; 40: 789-801
        • Singh S.M.
        • McCormick B.B.
        • Mustata S.
        • et al.
        Extracorporeal management of valproic acid overdose: a large regional experience.
        J Nephrol. 2004; 17: 43-49
        • Sullivan J.
        • Krieger G.
        Clinical environmental health and toxic exposures.
        2nd edition. Lippincott Williams & Wilkins, Philadelphia2001
      4. Toxicologic profiles ATSDR. Available at: http://www.atsdr.cdc.gov/toxprofiles. Accessed November 2004.

        • Hoffman R.S.
        Thallium toxicity and the role of Prussian blue in therapy.
        Toxicol Rev. 2003; 22: 29-40
        • Alvarez F.G.
        • Guntupalli K.K.
        Isoniazid overdose: four case reports and review of the literature.
        Intensive Care Med. 1995; 21: 641-644
        • Boyer E.
        Goldfrank's toxicologic emergencies.
        7th edition. McGraw-Hill, New York2002
        • Panganiban L.R.
        • Makalinao I.R.
        • Corte-Maramba N.P.
        Rhabdomyolysis in isoniazid poisoning.
        J Toxicol Clin Toxicol. 2001; 39: 143-151
        • Siefkin A.D.
        • Albertson T.E.
        • Corbett M.G.
        Isoniazid overdose: pharmacokinetics and effects of oral charcoal in treatment.
        Hum Toxicol. 1987; 6: 497-501
        • Scolding N.
        • Ward M.J.
        • Hutchings A.
        • et al.
        Charcoal and isoniazid pharmacokinetics.
        Hum Toxicol. 1986; 5: 285-286
        • Brent J.
        • Vo N.
        • Kulig K.
        • et al.
        Reversal of prolonged isoniazid-induced coma by pyridoxine.
        Arch Intern Med. 1990; 150: 1751-1753
        • Santucci K.A.
        • Shah B.R.
        • Linakis J.G.
        Acute isoniazid exposures and antidote availability.
        Pediatr Emerg Care. 1999; 15: 99-101
        • Hornfeldt C.S.
        • Larson A.A.
        Adenosine receptors are not involved in theophylline-induced seizures.
        J Toxicol Clin Toxicol. 1994; 32: 257-265
        • Paloucek F.P.
        • Rodvold K.A.
        Evaluation of theophylline overdoses and toxicities.
        Ann Emerg Med. 1988; 17: 135-144
        • Glenn G.M.
        • Krober M.S.
        • Kelly P.
        • et al.
        Pyridoxine as therapy in theophylline-induced seizures.
        Vet Hum Toxicol. 1995; 37: 342-345
        • Sugimoto T.
        • Sugimoto M.
        • Uchida I.
        • et al.
        Inhibitory effect of theophylline on recombinant GABA(A) receptor.
        Neuroreport. 2001; 12: 489-493
        • Bahls F.H.
        • Ma K.K.
        • Bird T.D.
        Theophylline-associated seizures with “therapeutic” or low toxic serum concentrations: risk factors for serious outcome in adults.
        Neurology. 1991; 41: 1309-1312
        • Hoffman A.
        • Pinto E.
        • Gilhar D.
        Effect of pretreatment with anticonvulsants on theophylline-induced seizures in the rat.
        J Crit Care. 1993; 8: 198-202
        • Blake K.V.
        • Massey K.L.
        • Hendeles L.
        • et al.
        Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline-induced seizures in mice.
        Ann Emerg Med. 1988; 17: 1024-1028
      5. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
        J Toxicol Clin Toxicol. 1999; 37: 731-751
        • Goetz C.M.
        • Lopez G.
        • Dean B.S.
        • et al.
        Accidental childhood death from diphenhydramine overdosage.
        Am J Emerg Med. 1990; 8: 321-322
        • Koppel C.
        • Ibe K.
        • Tenczer J.
        Clinical symptomatology of diphenhydramine overdose: an evaluation of 136 cases in 1982 to 1985.
        J Toxicol Clin Toxicol. 1987; 25: 53-70
        • Feldman H.S.
        • Arthur G.R.
        • Covino B.G.
        Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog.
        Anesth Analg. 1989; 69: 794-801
        • Smith M.
        • Wolfram W.
        • Rose R.
        Toxicity-seizures in an infant caused by (or related to) oral viscous lidocaine use.
        J Emerg Med. 1992; 10: 587-590
        • Ryan C.A.
        • Robertson M.
        • Coe J.Y.
        Seizures due to lidocaine toxicity in a child during cardiac catheterization.
        Pediatr Cardiol. 1993; 14: 116-118
        • Jonville A.P.
        • Barbier P.
        • Blond M.H.
        • et al.
        Accidental lidocaine overdosage in an infant.
        J Toxicol Clin Toxicol. 1990; 28: 101-106
        • Rosenberg P.H.
        • Kalso E.A.
        • Tuominen M.K.
        • et al.
        Acute bupivacaine toxicity as a result of venous leakage under the tourniquet cuff during a Bier block.
        Anesthesiology. 1983; 58: 95-98
        • Arai T.
        • Kuzume K.
        Bupivicaine toxicity and Bier blocks.
        Anesthesiology. 1983; 59: 481
        • Sawaki K.
        • Ohno K.
        • Miyamoto K.
        • et al.
        Effects of anticonvulsants on local anaesthetic-induced neurotoxicity in rats.
        Pharmacol Toxicol. 2000; 86: 59-62
        • Momota Y.
        • Artru A.A.
        • Powers K.M.
        • et al.
        Posttreatment with propofol terminates lidocaine-induced epileptiform electroencephalogram activity in rabbits: effects on cerebrospinal fluid dynamics.
        Anesth Analg. 1998; 87: 900-906
        • Weinberg G.
        • Ripper R.
        • Feinstein D.L.
        • et al.
        Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity.
        Reg Anesth Pain Med. 2003; 28: 198-202
        • Weinberg G.L.
        • VadeBoncoeur T.
        • Ramaraju G.A.
        • et al.
        Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats.
        Anesthesiology. 1998; 88: 1071-1075
        • Ozucelik D.N.
        • Karcioglu O.
        • Topacoglu H.
        • et al.
        Toxicity following unintentional DDT ingestion.
        J Toxicol Clin Toxicol. 2004; 42: 299-303
        • Aks S.E.
        • Krantz A.
        • Hryhrczuk D.O.
        • et al.
        Acute accidental lindane ingestion in toddlers.
        Ann Emerg Med. 1995; 26: 647-651
        • Fischer T.F.
        Lindane toxicity in a 24-year-old woman.
        Ann Emerg Med. 1994; 24: 972-974
        • Kassner J.T.
        • Maher T.J.
        • Hull K.M.
        • et al.
        Cholestyramine as an adsorbent in acute lindane poisoning: a murine model.
        Ann Emerg Med. 1993; 22: 1392-1397
        • Burkhard P.R.
        • Burkhardt K.
        • Haenggeli C.A.
        • et al.
        Plant-induced seizures: reappearance of an old problem.
        J Neurol. 1999; 246: 667-670
        • Phelan III, W.J.
        Camphor poisoning: over-the-counter dangers.
        Pediatrics. 1976; 57: 428-431
        • Strang J.
        • Arnold W.N.
        • Peters T.
        Absinthe: what's your poison? Though absinthe is intriguing, it is alcohol in general we should worry about.
        BMJ. 1999; 319: 1590-1592
      6. Micromedex Healthcare Series. Poisindex. Available at: http://www.micromedex.com. Accessed November 2004.

        • Watson W.A.
        • Litovitz T.L.
        • Klein-Schwartz W.
        • et al.
        2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.
        Am J Emerg Med. 2004; 22: 335-404
        • Trestrail III, J.H.
        • Spartz M.E.
        Camphorated and castor oil confusion and its toxic results.
        Clin Toxicol. 1977; 11: 151-158
        • Ginn H.E.
        • Anderson K.E.
        • Mercier R.K.
        • et al.
        Camphor intoxication treated by lipid dialysis.
        JAMA. 1968; 203: 230-231
        • ACEP Clinical Policies Committee
        Clinical Policies Subcommittee on Seizures. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures.
        Ann Emerg Med. 2004; 43: 605-625
        • Alldredge B.K.
        • Gelb A.M.
        • Isaacs S.M.
        • et al.
        A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.
        N Engl J Med. 2001; 345: 631-637
        • Alldredge B.K.
        • Lowenstein D.H.
        • Simon R.P.
        Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures.
        Am J Med. 1989; 87: 645-648
        • Chance J.F.
        Emergency department treatment of alcohol withdrawal seizures with phenytoin.
        Ann Emerg Med. 1991; 20: 520-522
        • Earnest M.P.
        • Marx J.A.
        • Drury L.R.
        Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage.
        JAMA. 1983; 249: 762-765
        • Hodges B.M.
        • Mazur J.E.
        Intravenous valproate in status epilepticus.
        Ann Pharmacother. 2001; 35: 1465-1470
        • Yu K.T.
        • Mills S.
        • Thompson N.
        • et al.
        Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures.
        Epilepsia. 2003; 44: 724-726
        • Kumar P.
        • Vallis C.J.
        • Hall C.M.
        Intravenous valproate associated with circulatory collapse.
        Ann Pharmacother. 2003; 37: 1797-1799
        • White J.R.
        • Santos C.S.
        Intravenous valproate associated with significant hypotension in the treatment of status epilepticus.
        J Child Neurol. 1999; 14: 822-823
        • Sinha S.
        • Naritoku D.K.
        Intravenous valproate is well tolerated in unstable patients with status epilepticus.
        Neurology. 2000; 55: 722-724